Insider Selling: Neuralstem Insider Sells 10,000 Shares of Stock (CUR)
Neuralstem (NYSE:CUR) Insider Karl Johe sold 10,000 shares of the company’s stock in a transaction dated Friday, October 18th. The stock was sold at an average price of $2.44, for a total value of $24,400.00. Following the completion of the sale, the insider now directly owns 694,994 shares in the company, valued at approximately $1,695,785. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Separately, analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note to investors on Friday, August 16th.
Shares of Neuralstem (NYSE:CUR) traded down 3.75% during mid-day trading on Monday, hitting $2.31. The stock had a trading volume of 766,082 shares. Neuralstem has a 52 week low of $0.88 and a 52 week high of $3.02. The stock’s 50-day moving average is $2.4 and its 200-day moving average is $1.66. The company’s market cap is $165.5 million.
Neuralstem (NYSE:CUR) last released its earnings data on Friday, August 9th. The company reported ($0.09) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.05) by $0.04. The company had revenue of $0.00 million for the quarter, compared to the consensus estimate of $0.08 million. Analysts expect that Neuralstem will post $-0.22 EPS for the current fiscal year.
Neuralstem, Inc is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.